ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies.

Aparna Hegde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.